ProfileGDS4459 / ENSG00000176225
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 51% 63% 68% 61% 79% 69% 57% 74% 73% 70% 77% 70% 72% 74% 76% 65% 74% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.4751
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.8763
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.2968
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.8661
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.0579
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.2269
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.7357
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.6674
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.6273
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.4170
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.8177
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.4670
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.4572
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.3874
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.976
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.9665
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.4474